{"name":"Ahn-Gook Pharmaceuticals Co.,Ltd","slug":"ahn-gook-pharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":20,"colorKey":"oncology","drugs":[{"name":"AGU (Active Comparator)","genericName":"AGU (Active Comparator)","slug":"agu-active-comparator","indication":"Phase 3 clinical trials","status":"phase_3"},{"name":"AG2202R","genericName":"AG2202R","slug":"ag2202r","indication":"Other","status":"phase_1"},{"name":"AG2202T","genericName":"AG2202T","slug":"ag2202t","indication":"Other","status":"phase_1"},{"name":"AG2304R","genericName":"AG2304R","slug":"ag2304r","indication":"Other","status":"phase_3"},{"name":"AGR tablet","genericName":"AGR tablet","slug":"agr-tablet","indication":"unknown","status":"phase_3"},{"name":"AGSAVI","genericName":"AGSAVI","slug":"agsavi","indication":"Other","status":"phase_3"},{"name":"AGSPT_20","genericName":"AGSPT_20","slug":"agspt-20","indication":"Other","status":"phase_1"},{"name":"AG1321001(drug)","genericName":"AG1321001(drug)","slug":"ag1321001-drug","indication":"Unknown","status":"phase_3"},{"name":"AG1502","genericName":"AG1502","slug":"ag1502","indication":"Other","status":"phase_1"},{"name":"AG2304","genericName":"AG2304","slug":"ag2304","indication":"Other","status":"phase_1"},{"name":"AG23041 and AG23042","genericName":"AG23041 and AG23042","slug":"ag23041-and-ag23042","indication":"Other","status":"phase_1"},{"name":"AGSAV301","genericName":"AGSAV301","slug":"agsav301","indication":"Other","status":"phase_1"},{"name":"AGSCT101 12.5mg","genericName":"AGSCT101 12.5mg","slug":"agsct101-12-5mg","indication":"Other","status":"phase_3"},{"name":"AGSPT201 Tab contains S-pantoprazole","genericName":"AGSPT201 Tab contains S-pantoprazole","slug":"agspt201-tab-contains-s-pantoprazole","indication":"Gastroesophageal reflux disease (GERD)","status":"phase_3"},{"name":"AGSPT_10","genericName":"AGSPT_10","slug":"agspt-10","indication":"Other","status":"phase_1"},{"name":"AGSPT_40","genericName":"AGSPT_40","slug":"agspt-40","indication":"Other","status":"phase_1"},{"name":"AGSPT_L20","genericName":"AGSPT_L20","slug":"agspt-l20","indication":"Other","status":"phase_1"},{"name":"AGT2","genericName":"AGT2","slug":"agt2","indication":"Other","status":"phase_3"},{"name":"AGT2, AGZ","genericName":"AGT2, AGZ","slug":"agt2-agz","indication":"Other","status":"phase_3"},{"name":"Carvedilol 25mg","genericName":"Carvedilol 25mg","slug":"carvedilol-25mg","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"neuroscience","drugs":[{"name":"AG20011","genericName":"AG20011","slug":"ag20011","indication":"Metastatic non-small cell lung cancer","status":"phase_3"},{"name":"AG20012","genericName":"AG20012","slug":"ag20012","indication":"Metastatic non-small cell lung cancer","status":"phase_3"},{"name":"AG2304T","genericName":"AG2304T","slug":"ag2304t","indication":"Metastatic non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"AGS (Experimental)","genericName":"AGS (Experimental)","slug":"ags-experimental","indication":"Metastatic non-small cell lung cancer, PD-L1 positive","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"AG NPP709syrup","genericName":"AG NPP709syrup","slug":"ag-npp709syrup","indication":"Hypertension","status":"phase_3"},{"name":"AGT4","genericName":"AGT4","slug":"agt4","indication":"Hypertension","status":"phase_3"},{"name":"AGT4, AGZ","genericName":"AGT4, AGZ","slug":"agt4-agz","indication":"Hypertension","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"AG2001","genericName":"AG2001","slug":"ag2001","indication":"Treatment of COVID-19","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"AGLS","genericName":"AGLS","slug":"agls","indication":"Treatment of type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"AGU (Active Comparator)","genericName":"AGU (Active Comparator)","slug":"agu-active-comparator","phase":"phase_3","mechanism":"AGU is an active comparator used in clinical trials.","indications":["Phase 3 clinical trials"],"catalyst":""},{"name":"AG2202R","genericName":"AG2202R","slug":"ag2202r","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AG2202T","genericName":"AG2202T","slug":"ag2202t","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AG2304R","genericName":"AG2304R","slug":"ag2304r","phase":"phase_3","mechanism":"AG2304R is an investigational therapeutic in phase 3 development by Ahn-Gook Pharmaceuticals with an undisclosed mechanism of action.","indications":[],"catalyst":""},{"name":"AGR tablet","genericName":"AGR tablet","slug":"agr-tablet","phase":"phase_3","mechanism":"AGR tablet is a small molecule drug that targets the molecular target.","indications":["unknown"],"catalyst":""},{"name":"AGSAVI","genericName":"AGSAVI","slug":"agsavi","phase":"phase_3","mechanism":"AGSAVI is an investigational therapeutic agent in Phase 3 development by Ahn-Gook Pharmaceuticals, but its specific mechanism of action is not publicly disclosed.","indications":[],"catalyst":""},{"name":"AGSPT_20","genericName":"AGSPT_20","slug":"agspt-20","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AG NPP709syrup","genericName":"AG NPP709syrup","slug":"ag-npp709syrup","phase":"phase_3","mechanism":"AG NPP709 syrup is a medication that targets the renin-angiotensin system to treat hypertension.","indications":["Hypertension"],"catalyst":""},{"name":"AG1321001(drug)","genericName":"AG1321001(drug)","slug":"ag1321001-drug","phase":"phase_3","mechanism":"AG1321001 is a small molecule drug that targets the molecular target.","indications":["Unknown"],"catalyst":""},{"name":"AG1502","genericName":"AG1502","slug":"ag1502","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AG2001","genericName":"AG2001","slug":"ag2001","phase":"phase_3","mechanism":"AG2001 is a small molecule that targets the SARS-CoV-2 main protease.","indications":["Treatment of COVID-19"],"catalyst":""},{"name":"AG20011","genericName":"AG20011","slug":"ag20011","phase":"phase_3","mechanism":"AG20011 is a small molecule targeting the PI3K/AKT/mTOR pathway.","indications":["Metastatic non-small cell lung cancer","Metastatic breast cancer"],"catalyst":""},{"name":"AG20012","genericName":"AG20012","slug":"ag20012","phase":"phase_3","mechanism":"AG20012 is a small molecule that targets the PI3K/AKT/mTOR pathway.","indications":["Metastatic non-small cell lung cancer","Metastatic breast cancer"],"catalyst":""},{"name":"AG2304","genericName":"AG2304","slug":"ag2304","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AG23041 and AG23042","genericName":"AG23041 and AG23042","slug":"ag23041-and-ag23042","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AG2304T","genericName":"AG2304T","slug":"ag2304t","phase":"phase_3","mechanism":"AG2304T is a small molecule targeting the PD-1 receptor.","indications":["Metastatic non-small cell lung cancer, PD-L1 positive","Metastatic melanoma"],"catalyst":""},{"name":"AGLS","genericName":"AGLS","slug":"agls","phase":"phase_3","mechanism":"AGLS is a small molecule that targets the SGLT2 receptor.","indications":["Treatment of type 2 diabetes"],"catalyst":""},{"name":"AGS (Experimental)","genericName":"AGS (Experimental)","slug":"ags-experimental","phase":"phase_3","mechanism":"AGS is an experimental drug that targets the PD-1/PD-L1 pathway.","indications":["Metastatic non-small cell lung cancer, PD-L1 positive","Metastatic melanoma"],"catalyst":""},{"name":"AGSAV301","genericName":"AGSAV301","slug":"agsav301","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AGSCT101 12.5mg","genericName":"AGSCT101 12.5mg","slug":"agsct101-12-5mg","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AGSPT201 Tab contains S-pantoprazole","genericName":"AGSPT201 Tab contains S-pantoprazole","slug":"agspt201-tab-contains-s-pantoprazole","phase":"phase_3","mechanism":"S-pantoprazole inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion.","indications":["Gastroesophageal reflux disease (GERD)","Peptic ulcer disease","Acid-related gastrointestinal disorders"],"catalyst":""},{"name":"AGSPT_10","genericName":"AGSPT_10","slug":"agspt-10","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AGSPT_40","genericName":"AGSPT_40","slug":"agspt-40","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AGSPT_L20","genericName":"AGSPT_L20","slug":"agspt-l20","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AGT2","genericName":"AGT2","slug":"agt2","phase":"phase_3","mechanism":"AGT2 is an investigational drug with unknown mechanism of action.","indications":[],"catalyst":""},{"name":"AGT2, AGZ","genericName":"AGT2, AGZ","slug":"agt2-agz","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AGT4","genericName":"AGT4","slug":"agt4","phase":"phase_3","mechanism":"AGT4 is an angiotensin II receptor antagonist.","indications":["Hypertension"],"catalyst":""},{"name":"AGT4, AGZ","genericName":"AGT4, AGZ","slug":"agt4-agz","phase":"phase_3","mechanism":"AGT4 and AGZ are angiotensin II receptor blockers.","indications":["Hypertension","Heart failure"],"catalyst":""},{"name":"Carvedilol 25mg","genericName":"Carvedilol 25mg","slug":"carvedilol-25mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxNWENFMUNZNzVWZXB2UUZpbXBWMmJ5aVFrZVliN1VXMnA2MVVNc29TclhTRWV4eWZiSlZnNGU5cmpYSlhSOFlNaGc2bUx1bFNtRWkxTXhNeEVsWWlFQ3RmTk1fQzZrVzBGVkJocFJZdHh6V19MWjM3dzFrZk9ZQXoxOHBocFlXaUp1ZWN1VzMwc3hEYmV1MHB0QnF0OXBSQ3ZKNlBTOE53RFBfSkZjME1uODVHaWpWWUZSbldBX29xZ2dWZ2tCTVVIeXJzc2oyNU1WSXdfNmFjWWphclhUbDN4eXFvQVBzeXZCeDdyX0d0OUxXX1lLOFFuaFg0a3JoWUFTem9RT3ctb2U2cEZDY3FlNWhvNW_SAZoCQVVfeXFMUEdpXzU2XzFTZGRMVFlmUDU5czZ3RktJaTJoNVZsWmhHMnNNRW5faFZpaU1GTmM3YnNvemRyMlJYZktsWFpLNWtWVGdTSk1JbDZUYTBRb0lvSHVreFN2dTlUZ0VGOFM3c3JpQXdaa0kyaWI3YjdIUEdHa0FwZnlrT0V6RUZGTkRVeHBNNUp1S25PZGRhSW9JRk43Y2p5NDgtNUlaWjJWX2RZeTRtZElESDlTR0taUHROejRuc0RRX0I3WVBRbXpKLTVjdDJlT2d5TmYxQ3hBNGVrUVRReHpNUjFGZTFlR3RCYm9pOGFQal9HbUd3T3FKUFJDRTJxX0NCNmVUODBFd3JESVVXd2hUdU9ORXUwWEp4dWJB?oc=5","date":"2026-03-11","type":"pipeline","source":"The Manila Times","summary":"George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea - The Manila Times","headline":"George Medicines signs exclusive licensing agreement with Ahngook Pharmaceutical to commercialize GMRx2 in Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPY2IzOHRaMWxITzlncERQXzd6bUJQRzZuMWM2RlZhU0Q0aUE0SlR4R0pFbF9DOFNXRnpJLVNCWHFQZFRuY3FKeGRVbWt4RjlEbWo2OGNUY0JVcUg4M2NCXy1yaXFoRDNkU080TXFmODh5UjZzMWdDSmJuY1NQV0pLUWVB0gGWAUFVX3lxTE9STXA0MW1WaWdfNzlGY0ZyZ2RyV1ZXVGQzUWdvOEVCdGVLSVJxRzlkaWtFeFh5NlhOU1BVV3ZRTnRKRkZGa2ZzMUtMVUtZdWhPMHR5WmxfdlRMbnpQdkp2NWFvTUhxMktQVnNxREdNaG1VVjJrWWJQemdGa3A1Vnc3anRPelhSVS10T2IxTWpFbXotOHp4Zw?oc=5","date":"2026-01-27","type":"pipeline","source":"Chosunbiz","summary":"South Korea SMEs accelerate M&A for growth and succession - CHOSUNBIZ - Chosunbiz","headline":"South Korea SMEs accelerate M&A for growth and succession - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5XTzIwM25ScUZLbklOY21IUEpLUnRRaTVzcXctMHR5anktWWo2a2V0Z2JCblFJM1AwS25kRHViVkd5LUl5c0NPdFVOaFFMY3VUVlJDc29saGNQQWNpQjJFNlJHZWVnWS1LSmdEYk9B0gFyQVVfeXFMUHdweFR5V1hiWnl1UVpSX011Tjh4eDJ6Qzl3LWVPNWl5LXpmUk9vcmRQZ3VsVDByY2MxN1I0VmZON2c5bXFfcjlIMmVOcm1TUFhSMG1TWWFGYk9VdjNlclRyQ1FfdnBPbndBMXgwMU1JM1lB?oc=5","date":"2025-11-19","type":"deal","source":"koreabiomed.com","summary":"Ahngook Pharm acquires Dimedi Korea to expand health tech and H&B portfolio - koreabiomed.com","headline":"Ahngook Pharm acquires Dimedi Korea to expand health tech and H&B portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOblo3SlB6ZGFBaGR1enFLRHB5cl9TbGNRMlRGLWFVRmdmeFBqQVpEdHMtaDdkdndHVVB4Z1Vnc09NVWs4TzVobWlSM1B5eVFZWUNubUJNeTBtR0NxS0dQXzJmdjVrd0NHVE10ZFpCMFlsS2VzVTg5bkhMQ0stNUZOdm1QZk1lSkxGU21hWGE3Q3F4Mm1SY0NUdU15bjZULXJwQ2pab2p5cmdYWUtVbUE?oc=5","date":"2025-04-11","type":"pipeline","source":"The Pharma Letter","summary":"Novartis investing $23 billion to expand production and R&D in USA - The Pharma Letter","headline":"Novartis investing $23 billion to expand production and R&D in USA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5Ed0R0dWVoX3M2cTJRbDRWbjFSWVMxdnJLSVRSekx3YkVBblh5ZHhsTHNCWkxsQ3h5N0RlbzF4c3JxSjBOeFM5aEpoM3paSzBmMEZZb2V5b21XR3ZyY1hub3IySlpSUDB5ZXdLX1ZR0gFyQVVfeXFMUDhxVklhV0NKTzdOWjBqSnQ3Z3ZTUFpRQ2otQ3ZuYTlUaTNNQ2RkRUoySS02NjVyeVBfdVFKX2xhUjNtNFFYdDhNdDhyc1A0UU1IdElrYXU2LWthZVY3VFRVOTNpaWZDaHozcWFWQlBrckN3?oc=5","date":"2025-01-03","type":"pipeline","source":"koreabiomed.com","summary":"Ahngook Pharmaceutical names marketing expert Park as new CEO to lead sales growth - koreabiomed.com","headline":"Ahngook Pharmaceutical names marketing expert Park as new CEO to lead sales growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFA5RnZiUFhLdHEwY2o4TEtVd2xobXdaTFFuQ2NEZzRqU2FEVnJkQ2JyRjROM0Q0cnFMLU83QkV6QlE4eTk2N2xURkdBVE1qdm9xQ2dCNGhTRUIxYXhQTW82djYyXzh5SXloOXd5eF9B0gFyQVVfeXFMUEs0cDB2NWNnRk0xR19HU0dmWkFaWjJDbm9HSXNMZHdnRlk3dVBuV1R5dVQzTk0yLXl6OUFmM3J2X01YMjVqTnA2TzFKRjNfdTJ5QmJHa1NUbEN1VDJ6UWhZdm84VUdqbWpRTXp6WHpaRDl3?oc=5","date":"2023-10-11","type":"pipeline","source":"koreabiomed.com","summary":"New drug mispackaging incident hits 2 pharma firms - koreabiomed.com","headline":"New drug mispackaging incident hits 2 pharma firms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE90RHM5Wk9BX2xMMmM3VzdoVWJIWUstR0l5a2Z2Y1JpQjN2emJLUVBMSy1VZHoxY0QwZHFsRjhuelNreGxtc3JmQndHWEZRX1ZGYVdPMFhOMUZjQlNRR2o3elR5WXl5eXl4WWF6ddIBcEFVX3lxTE9oZFJoU2dBODk4eTJNdG5HbXM2VVlJajR6OWFkWGRtRTFkbFNWM0xWM1RhZGdYb3IyV19PbHNPX094cE91dUxBc0FCbjR5OGFCc0s3dVFvTm51MHpjcGxLR0pMVExRMGp1VU9CUzRKSWk?oc=5","date":"2017-09-05","type":"pipeline","source":"koreabiomed.com","summary":"Ahngook gets state support for new drug - koreabiomed.com","headline":"Ahngook gets state support for new drug","sentiment":"neutral"}],"patents":[],"drugCount":29,"phaseCounts":{"phase_3":18,"phase_1":10,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}